Vacuum Cleaners Discussions

ORECK - The business, the history, the machine, the man and related.

(Below: Oreck 1979 to 2008)

  < yr. 1979  < yr. 5/2008

ORECK, as an 8/9 pound  lightweight vacuum is and always has been an equal contender with all the full sized vacuums on the market for the last 45 years.  That's the reason its still the best in its class and others try to imitate/compete.  Not many can/do.  The jury is still out on the DC24.  Which is 4 pounds heavier.  Almost the same weight as the ORECK compact canister.

Carmine D.

CarmineD wrote:

Hello,

My understanding of getting an extension - only if there was some sort of delay in the obtaining/getting approval for a patent and mostly drug related patents.  And I think it is no longer than 5 years at most.

 

I do not know the answer for sure.  My guess is no, society comes first and inventors come second.  Q:  Can an inventor prevent society from *benefiting from a widget if the original inventor keeps tweaking a product and locking up (monopolizing) the entire widget for an additional 20 year patent period.  My guess is no.  I'm sure James would of loved to have been able to tweak his dual cyclone and extend the patent life vesus competing against his own work in the market place.        DIB

 

*After a patent expires others can make for sale said widget and society “benefits”.

DysonInventsBig wrote:

Hello DIB:

With drugs the period is 3-10 years after the drug is publicly marketed.  More time with extensions if the maker claims the drug is tweaked.  Wonderful case currently being heard.  The drug is TRICOR.  The maker is trying to keep generics from market after patent expiration dates by arguing it's changed the drug along the way.  Competitors have taken the maker to court.  I predict the competition will win.  TRICOR's maker will bite the dust.

Carmine D.

Motorhead wrote:

Hello TOM:

Sort of like Air Way!  Is that brand vacuum still around and in business like ORECK and KIRBY?  What ever happened?  Who knows?  Who cares?   Topic unworthy. 

Carmine D.

CarmineD wrote:

Carmine,

That’s just it!  If society benefits, patent extensions for life saving or bettering drugs are given, but I do not believe it is the same for non-drug patents.

.

Can you link me 1 or 2 good articles that talk/follow this Tricor story?  Thanks.        DIB

CarmineD wrote:

cztlady did not think that the Oreck was that good.  I think you already know what she said.

CarmineD wrote:

The 07 and 14 do not have the same suction power.

I already did the kapock test.  Remember you brought this up when I recommended baking soda as a test.  BTW the Oreck still will not pass the baking soda test.

HARDSELL wrote:

Hello HARDSELL:

If I recall, catlady said the ORECK did not perform as good as the Miele.  My sense is the belt in the ORECK model [probably display/demo] needed replacing.  Belts must be replaced even if the vacuum is not used.

If my new vacuum budget was $600 and in the market for a full size, I'd opt for the Miele too over the ORECK.  Remember for $600, I bought 4 ORECK XL Classics and all the recipients rave over them!

Carmine D.

HARDSELL wrote:

Hello HARDSELL:

The difference in air watts between the two models [DC07/14] is so neglibible, it's insignificant.  In fact all the dyson models since have significantly less air watts than the DC07.  The improvement to allow dyson to skimp on the air watts after the DC07 and achieve better pick up is the improved brush roll design and function.  That's the reason these 2 models are getting scrubbed.   Only took Mr. Dyson and his 500 engineers [the innovative crew] 5 years to figure it out and make the necessary brush roll changes. 

Carmine D.

DysonInventsBig wrote:

DIB:

Society doesn't benefit by the drug patent holder claiming exclusive ad infinitum usage and charging high prices.  Society benefits when other drug makers offer generics at less cost.  Just as consumers don't benefit from $500 bagless dysons when $100-$200 bagless Dirt Devils, HOOVER-s, BISSELL-s etc perform as well. 

The Wall Street Journal has the best news coverage of the TRICOR drug case.  I'm a reader but not an on-line subscriber.  Sorry.   BTW, the WSJ appears to be on the side of the generics against TRICOR.  IMHO

Carmine D.